Skip to main content
Log in

Rhythmusstörungen bei chronischen Autoimmunerkrankungen

Cardiac arrhythmias in patients with chronic autoimmune diseases

  • Schwerpunkt
  • Published:
Herzschrittmachertherapie + Elektrophysiologie Aims and scope Submit manuscript

Zusammenfassung

Eine chronische Inflammation im Rahmen von Autoimmunerkrankungen ist mit einer erhöhten Rate an supraventrikulären und ventrikulären Arrhythmien vergesellschaftet, welche mit einer gesteigerten Morbidität und Mortalität assoziiert ist. Die Beteiligung des spezifischen Erregungsleitungssystems wird sehr häufig bei chronischen Autoimmunprozessen beobachtet, wenngleich die klinische Penetranz sehr unterschiedlich ist und therapiebedürftige Blockierungen nur selten auftreten. Für die Pathogenese tachykarder Arrhythmien scheint die Kombination aus der gesteigerten Prävalenz struktureller Herzerkrankungen und dem direkten Einfluss inflammatorischer Mechanismen auf die kardiale Elektrophysiologie ursächlich zu sein. Dabei werden vor allem die Fibroblastenaktivierung, eine gestörte Gap-Junction-Funktion durch Änderung der Connexin-Zusammensetzung sowie die Störung des intrazellulären Ca2+-Stoffwechsels angeführt. Als elektrokardiographische Marker eines erhöhten arrhythmogenen Risikos bei Patienten mit chronischen Autoimmunerkrankungen können eine verlängerte P‑Wellen-Dauer sowie eine abnorme QTc-Zeit und reduzierte Herzfrequenzvariabilität gelten. Die frühzeitige und konsequente inflammationshemmende Therapie rückt somit auch im Hinblick auf die Vermeidung von Arrhythmien in den Vordergrund.

Abstract

Chronic inflammation due to autoimmune diseases is associated with a higher rate of supraventricular and ventricular arrhythmias leading to an increased risk for cardiovascular morbidity and mortality. Involvement of the cardiac conduction system is common in patients with chronic autoimmune diseases, although the penetrance of clinical signs and symptoms is variable and complete heart block with need for therapy is rare. The combination of the increased prevalence of structural cardiovascular disease and the direct impact of inflammatory mechanisms on cardiac electrophysiology seems to be responsible for the higher rate of tachyarrhythmias. In particular, fibroblast activation, gap junction impairment via changes in connexin composition and abnormalities in intracellular calcium-handling are mentioned. Electrocardiographic markers of an increased arrhythmogenic potential in patients with chronic autoimmune disorders may include prolonged P‑wave duration as well as abnormal QTc interval and reduced heart rate variability. Thus, minimizing the inflammatory burden through tight control of disease activity may help reduce the arrhythmic load.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Rose NR (2016) Prediction and prevention of Autoimmune disease in the 21st century: a review and preview. Am J Epidemiol 183(5):403–406. https://doi.org/10.1093/aje/kwv292

    Article  PubMed  Google Scholar 

  2. Ng SC, Shi HY, Hamidi N et al (2018) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390(10114):2769–2778. https://doi.org/10.1016/S0140-6736(17)32448-0

    Article  PubMed  Google Scholar 

  3. Braun J, Müller-Wieland D, Altiok E et al (Hrsg) (2018) Basislehrbuch Innere Medizin, 6. Aufl. Elsevier, München

    Google Scholar 

  4. Bunu D‑M, Timofte C‑E, Ciocoiu M et al (2019) Cardiovascular manifestations of inflammatory bowel disease: pathogenesis, diagnosis, and preventive strategies. Gastroenterol Res Pract 2019:3012509. https://doi.org/10.1155/2019/3012509

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mason JC, Libby P (2015) Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J 36(8):482–49c. https://doi.org/10.1093/eurheartj/ehu403

    Article  PubMed  Google Scholar 

  6. Gabriel SE (2008) Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 121(10 Suppl 1):9–14. https://doi.org/10.1016/j.amjmed.2008.06.011

    Article  Google Scholar 

  7. Lazzerini PE, Capecchi PL, Laghi-Pasini F (2017) Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J 38(22):1717–1727. https://doi.org/10.1093/eurheartj/ehw208

    Article  CAS  PubMed  Google Scholar 

  8. Seferović PM, Ristić AD, Maksimović R et al (2006) Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxf) 45(Suppl 4):iv39–iv42. https://doi.org/10.1093/rheumatology/kel315

    Article  Google Scholar 

  9. Villecco AS, de Liberali E, Bianchi FB et al (1983) Antibodies to cardiac conducting tissue and abnormalities of cardiac conduction in rheumatoid arthritis. Clin Exp Immunol 53(3):536–540

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Lazzerini PE, Capecchi PL, Guideri F et al (2006) Connective tissue diseases and cardiac rhythm disorders: an overview. Autoimmun Rev 5(5):306–313. https://doi.org/10.1016/j.autrev.2005.11.002

    Article  PubMed  Google Scholar 

  11. Tselios K, Gladman DD, Harvey P et al (2018) Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors. Lupus 27(9):1415–1423. https://doi.org/10.1177/0961203318770526

    Article  CAS  PubMed  Google Scholar 

  12. Maisch B, Ristić AD (2001) Immunological basis of the cardiac conduction and rhythm disorders. Eur Heart J 22(10):813–824. https://doi.org/10.1053/euhj.2000.2186

    Article  CAS  PubMed  Google Scholar 

  13. Janosik DL, Osborn TG, Moore TL et al (1989) Heart disease in systemic sclerosis. Semin Arthritis Rheum 19(3):191–200

    Article  CAS  PubMed  Google Scholar 

  14. Wang Q, Shang Y, Li S et al (2018) Complete heart block in systemic sclerosis: a case report and literature review. Medicine (Baltimore) 97(46):e13226. https://doi.org/10.1097/MD.0000000000013226

    Article  Google Scholar 

  15. Guo Y, Lip GYH, Apostolakis S (2012) Inflammation in atrial fibrillation. J Am Coll Cardiol 60(22):2263–2270. https://doi.org/10.1016/j.jacc.2012.04.063

    Article  CAS  PubMed  Google Scholar 

  16. Ungprasert P, Srivali N, Kittanamongkolchai W (2017) Risk of incident atrial fibrillation in patients with rheumatoid arthritis: a systematic review and meta-analysis. Int J Rheum Dis 20(4):434–441. https://doi.org/10.1111/1756-185X.12820

    Article  CAS  PubMed  Google Scholar 

  17. Bacani AK, Crowson CS, Roger VL et al (2015) Increased incidence of atrial fibrillation in patients with rheumatoid arthritis. Biomed Res Int 2015:809514. https://doi.org/10.1155/2015/809514

    Article  PubMed  PubMed Central  Google Scholar 

  18. Kristensen SL, Lindhardsen J, Ahlehoff O et al (2014) Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study. Europace 16(4):477–484. https://doi.org/10.1093/europace/eut312

    Article  PubMed  Google Scholar 

  19. Hu Y‑F, Chen Y‑J, Lin Y‑J et al (2015) Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol 12(4):230–243. https://doi.org/10.1038/nrcardio.2015.2

    Article  CAS  PubMed  Google Scholar 

  20. Saba S, Janczewski AM, Baker LC et al (2005) Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-{alpha}. Am J Physiol Heart Circ Physiol 289(4):H1456–67. https://doi.org/10.1152/ajpheart.00733.2004

    Article  CAS  PubMed  Google Scholar 

  21. Yavuzkir M, Ozturk A, Dagli N et al (2007) Effect of ongoing inflammation in rheumatoid arthritis on P‑wave dispersion. J Int Med Res 35(6):796–802. https://doi.org/10.1177/147323000703500608

    Article  CAS  PubMed  Google Scholar 

  22. Guler H, Seyfeli E, Sahin G et al (2007) P wave dispersion in patients with rheumatoid arthritis: Its relation with clinical and echocardiographic parameters. Rheumatol Int 27(9):813–818. https://doi.org/10.1007/s00296-007-0307-8

    Article  PubMed  Google Scholar 

  23. Issac TT, Dokainish H, Lakkis NM (2007) Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 50(21):2021–2028. https://doi.org/10.1016/j.jacc.2007.06.054

    Article  CAS  PubMed  Google Scholar 

  24. Zaccardi F, Khan H, Laukkanen JA (2014) Diabetes mellitus and risk of sudden cardiac death: a systematic review and meta-analysis. Int J Cardiol 177(2):535–537. https://doi.org/10.1016/j.ijcard.2014.08.105

    Article  PubMed  Google Scholar 

  25. Mackey RH, Kuller LH, Deane KD et al (2015) Rheumatoid arthritis, anti-cyclic Citrullinated peptide Positivity, and cardiovascular disease risk in the women’s health initiative. Arthritis Rheumatol 67(9):2311–2322. https://doi.org/10.1002/art.39198

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Panoulas VF, Toms TE, Douglas KMJ et al (2014) Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatol (oxford) 53(1):131–137. https://doi.org/10.1093/rheumatology/ket338

    Article  Google Scholar 

  27. Chauhan K, Ackerman MJ, Crowson CS et al (2015) Population-based study of QT interval prolongation in patients with rheumatoid arthritis. Clin Exp Rheumatol 33(1):84–89

    PubMed  PubMed Central  Google Scholar 

  28. Lazzerini PE, Acampa M, Capecchi PL et al (2015) Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: Tocilizumab reduces corrected QT interval by controlling systemic inflammation. Arthritis Care Res (hoboken) 67(3):332–339. https://doi.org/10.1002/acr.22455

    Article  CAS  Google Scholar 

  29. Adlan AM, Lip GYH, Paton JFR et al (2014) Autonomic function and rheumatoid arthritis: a systematic review. Semin Arthritis Rheum 44(3):283–304. https://doi.org/10.1016/j.semarthrit.2014.06.003

    Article  PubMed  Google Scholar 

  30. Lazzerini PE, Acampa M, Hammoud M et al (2008) Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, crossover study in patients with chronic arthritis. J Rheumatol 35(10):1958–1965

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin Neef.

Ethics declarations

Interessenkonflikt

M. Neef, K. Berndt, C. Spies, U. Laufs und M. Metze geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Neef, M., Berndt, K., Spies, C. et al. Rhythmusstörungen bei chronischen Autoimmunerkrankungen. Herzschr Elektrophys 30, 240–244 (2019). https://doi.org/10.1007/s00399-019-00636-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00399-019-00636-z

Schlüsselwörter

Keywords

Navigation